Medtronic gets FDA nod for implantable neuromod for urinary incontinence
September 19, 2025
Medtronic (NYSE: MDT)+
announced today that it received FDA approval for its Altaviva neuromodulation device.
Medtronic (NYSE: MDT)+
announced today that it received FDA approval for its Altaviva neuromodulation device.
CAESAREA, Israel, Sept. 18, 2025 /PRNewswire/ — IceCure Medical Ltd. (NASDAQ: ICCM) (“IceCure”, “IceCure Medical” or the “Company”), developer of minimally-invasive cryoablation technology that destroys tumors by freezing as an option to surgical tumor removal, today announced it has received a Notice of Allowance from the U.S. Patent and Trademark Office for its patent titled “Cryoprobe”.
The company is working to obtain CE marking of the system in the European Union.
OrganOx announced today that it received FDA approval for the use of its normothermic machine perfusion (NMP) device during air transport.
Jupiter Endovascular announced today that its Vertex catheter received FDA 510(k) clearance for the insertion of endovascular devices.
Durham, NC — September 16, 2025 — SutureTech, a surgeon-founded medical device company focused on advancing soft tissue and tendon repair, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for RapidFix™, its flagship device.
WALTHAM, Mass., Sept. 16, 2025 /PRNewswire/ — Body Vision Medical, a global leader in AI-powered intraoperative imaging, is proud to announce that its LungVision AI-powered advanced imaging system has received regulatory approval from the Central Drugs Standard Control Organization (CDSCO) in India. This approval marks a significant milestone in the company’s mission to improve early and accurate lung cancer diagnosis worldwide.
BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation system to include an accelerated treatment protocol for major depressive disorder and patients with comorbid anxiety symptoms.
MicroPort CardioFlow said its Alwide Plus balloon catheter has received CE mark approval, clearing the company to market the device in Europe.
Roche announced today that it received CE mark for the integration of its Accu-Chek SmartGuide CGM with the mySugr app.